BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15640819)

  • 1. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia.
    George B; Mathews V; Shaji RV; Srivastava V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2005 Feb; 35(4):341-3. PubMed ID: 15640819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
    Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
    Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation.
    Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Moussa E; Karaoui M; Roberts G; El-Solh H
    Bone Marrow Transplant; 2004 Jan; 33(1):15-7. PubMed ID: 14578932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia.
    Kapelushnik J; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1997 Dec; 20(12):1109-10. PubMed ID: 9466288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
    Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
    Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
    Farzana T; Shamshi TS; Irfan M; Ansari SH; Baig MI; Shakoor N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin.
    Ayas M; Solh H; Mustafa MM; Al-Mahr M; Al-Fawaz I; Al-Jefri A; Shalaby L; Al-Nasser A; Al-Sedairy R
    Bone Marrow Transplant; 2001 Jan; 27(2):139-43. PubMed ID: 11281382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    de la Fuente J; Reiss S; McCloy M; Vulliamy T; Roberts IA; Rahemtulla A; Dokal I
    Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
    Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation in Fanconi anemia from Turkey: a report of four cases.
    Tezcan I; Tuncer M; Uçkan D; Cetin M; Alikaşifoğlu M; Ersoy F; Altay C
    Pediatr Transplant; 1998 Aug; 2(3):236-9. PubMed ID: 10084749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Related donor hematopoietic stem cell transplantation for Fanconi anemia without radiation: a single center experience in Turkey.
    Ertem M; Ileri T; Azik F; Uysal Z; Gozdasoglu S
    Pediatr Transplant; 2009 Feb; 13(1):88-95. PubMed ID: 18433407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
    Zwaan CM; Van Weel-Sipman MH; Fibbe WE; Oudshoorn M; Vossen JM
    Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.